We aimed to evaluate whether emergency contraception with levonorgestrel (LNG-EC) administered after ovulation is equally effective to LNG-EC administered before ovulation.
Herewith, tumorigenic potential of CD44+ fraction exceeded that of total population of EC cells administered in the same doses (in 23 and 21 times, respectively).
EC was administered orally at 3 h after ICH and then every 24 h.
(3) After EC, we administered the amino acids as soon as the rats awoke from anesthesia, which took 10 min.
When neutrophil count was below 1×10 l−1 and/or platelet count was below 75×10 l−1 at day 14, the second EC was administered with 90 mg m−2 EPI and 1.5 g m−2 CPA.
Trace levels of ECH were detected in DCP dose formulations corresponding to 0.0239 and 0.0197 μmol ECH/kg administered in males and females, respectively, suggesting that animals received negligible amounts of ECH compared to DCP via administration of DCP.
To prove the special role of CD44+ cells in initiation and maintenance of tumor when administered EC even in minimal doses, it was of interest to comparatively assess the tumorigenic capacity of isolated CD44+ and CD44– fractions when administered at various concentrations.
Emergency contraception (EC) is contraception administered after unprotected intercourse.
To determine whether the effects on ICH injury were due to activation of the Nrf2 pathway, we administered EC (15 mg/kg per day) to Nrf2 KO mice with or without ICH.
We crossed α-pvfl/fl mice with Cadh5(PAC -CreERT2 mice, induced α-PAC -CreERT2tion in ECs by admicesterinducedonsecutive intraperitoneal injections of tamoxifen in newborns starting at P1, and analyzed retinal vascularization over time.
To define the optimal dose of EC in ICH, we first administered different doses of EC to 12-month-old male mice subjected to collagenase injection.
